R&D

A world premiere from Erasmus MC and Utrecht University: they found an antibody against COVID-19

Since Thursday evening, the article by a team of ten scientists has been online on BioRxiv - a website where biologists can publish their research before it will be assessed by the prestigious journal Nature. In the summary, the scientists describe an antibody to SARS2, the coronavirus causing the current pandemic (COVID-19). The antibody can help detect and prevent this type of corona infection.

Individual response to COVID-19 'as important' as government action

How individuals respond to government advice on preventing the spread of COVID-19 will be at least as important, if not more important, than government action, according to a new commentary from researchers at the University of Oxford and Imperial College London in the UK, and Utrecht University and the National Institute for Public Health and the Environment in the Netherlands.

Preventing spread of SARS coronavirus-2 in humans

Several coronaviruses circulate worldwide and constantly infect humans, which normally caused only mild respiratory disease. Currently, however, we are witnessing a worldwide spread of a new coronavirus with more than 90,000 confirmed cases and over 3,000 deaths. The new virus has been named SARS coronavirus-2 and has been transmitted from animals to humans. It causes a respiratory disease called COVID-19 that may take a severe course.

COVID-19 a reminder of the challenge of emerging infectious diseases

The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, pose complex challenges to the global public health, research and medical communities, write federal scientists from NIH's National Institute of Allergy and Infectious Diseases (NIAID) and from the Centers for Disease Control and Prevention (CDC). Their commentary appears in The New England Journal of Medicine.

Study reveals how drug meant for Ebola may also work against coronaviruses

A group of University of Alberta researchers who have discovered why the drug remdesivir is effective in treating the coronaviruses that cause Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS) expect it might also be effective for treating patients infected with the new COVID-19 strain.

Study sheds light on how a drug being tested in COVID-19 patients works

A team of academic and industry researchers is reporting new findings about how exactly an investigational antiviral drug stops coronaviruses. Their paper was published the same day that the National Institutes of Health announced that the drug in question, remdesivir, is being used in the nation's first clinical trial of an experimental treatment for COVID-19, the illness caused by the SARS-CoV-2 virus.

HKUST scientists shed light on COVID-19 vaccine development

A team of scientists at the Hong Kong University of Science and Technology (HKUST) has recently made an important discovery in identifying a set of potential vaccine targets for the SARS-CoV-2 coronavirus, providing crucial leads for guiding experimental efforts towards the vaccine development against the novel pneumonia (COVID-19) caused by the virus.

Research & Development

A world premiere from Erasmus MC and Utrecht University: they found an antibody against COVID-19

Individual response to COVID-19 'as important' as government action

Preventing spread of SARS coronavirus-2 in humans

COVID-19 a reminder of the challenge of emerging infectious diseases

Study reveals how drug meant for Ebola may also work against coronaviruses

Study sheds light on how a drug being tested in COVID-19 patients works

HKUST scientists shed light on COVID-19 vaccine development

More Pharma News ...